메뉴 건너뛰기




Volumn 3, Issue 4, 2014, Pages

Prediction of efficacy of vabicaserin, a 5-HT2C agonist, for the treatment of schizophrenia using a quantitative systems pharmacology model

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; ILOPERIDONE; MELPERONE; MUSCARINIC M1 RECEPTOR; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PIMOZIDE; QUETIAPINE; REMOXIPRIDE; RISPERIDONE; SEROTONIN 2C RECEPTOR; SERTINDOLE; VABICASERIN; ZIPRASIDONE; ZOTEPINE;

EID: 84902488722     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2014.7     Document Type: Article
Times cited : (39)

References (31)
  • 1
    • 79956204058 scopus 로고    scopus 로고
    • Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist
    • Dunlop, J. et al. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist. J. Pharmacol. Exp. Ther. 337, 673-680 (2011).
    • (2011) J. Pharmacol. Exp. Ther. , vol.337 , pp. 673-680
    • Dunlop, J.1
  • 3
    • 36549008159 scopus 로고    scopus 로고
    • The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors
    • DOI 10.1016/j.ejphar.2007.08.045, PII S0014299907009946
    • Wang, R. et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 578, 43-50 (2008). (Pubitemid 350179755)
    • (2008) European Journal of Pharmacology , vol.578 , Issue.1 , pp. 43-50
    • Wang, R.1    Xu, Y.2    Wu, H.-L.3    Li, Y.-B.4    Li, Y.-H.5    Guo, J.-B.6    Li, X.-J.7
  • 5
    • 84878821597 scopus 로고    scopus 로고
    • A 6-week randomized, double-blind, placebocontrolled, comparatorreferenced, multicenter trial of vabicaserin in subjects with acute exacerbation of schizophrenia
    • Shen, J. et al. A 6-week randomized, double-blind, placebocontrolled, comparatorreferenced, multicenter trial of vabicaserin in subjects with acute exacerbation of schizophrenia. Neuropsychopharmacology 36, S106 (2011).
    • (2011) Neuropsychopharmacology , vol.36
    • Shen, J.1
  • 6
    • 70350338847 scopus 로고    scopus 로고
    • Of mice and men: Bridging the translational disconnect in CNS drug discovery
    • Geerts, H. of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs 23, 915-926 (2009).
    • (2009) CNS Drugs , vol.23 , pp. 915-926
    • Geerts, H.1
  • 7
    • 84862896528 scopus 로고    scopus 로고
    • A Quantitative systems pharmacology computer model for schizophrenia efficacy and extrapyramidal side effects
    • Spiros, A., Roberts, P. & Geerts, H. A Quantitative systems pharmacology computer model for schizophrenia efficacy and extrapyramidal side effects. Drug Dev. Res. 73, 196-213 (2012).
    • (2012) Drug Dev. Res. , vol.73 , pp. 196-213
    • Spiros, A.1    Roberts, P.2    Geerts, H.3
  • 8
    • 84878760670 scopus 로고    scopus 로고
    • Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development
    • Geerts, H., Spiros, A., Roberts, P. & Carr, R. Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development. J. Pharmacokinet. Pharmacodyn. 40, 257-265 (2013).
    • (2013) J. Pharmacokinet. Pharmacodyn. , vol.40 , pp. 257-265
    • Geerts, H.1    Spiros, A.2    Roberts, P.3    Carr, R.4
  • 9
    • 84871348323 scopus 로고    scopus 로고
    • Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response
    • Geerts, H., Spiros, A., Roberts, P., Twyman, R., Alphs, L. & Grace, A.A. Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response. PLoS ONE 7, e49732 (2012).
    • (2012) PLoS ONE , vol.7
    • Geerts, H.1    Spiros, A.2    Roberts, P.3    Twyman, R.4    Alphs, L.5    Grace, A.A.6
  • 10
    • 67649321877 scopus 로고    scopus 로고
    • Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function
    • Abdallah, L. et al. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J. Neurosci. 29, 8156-8165 (2009).
    • (2009) J. Neurosci. , vol.29 , pp. 8156-8165
    • Abdallah, L.1
  • 11
    • 52649102034 scopus 로고    scopus 로고
    • Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat
    • Egerton, A., Ahmad, R., Hirani, E. & Grasby, P.M. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. Psychopharmacology (Berl.) 200, 487-496 (2008).
    • (2008) Psychopharmacology (Berl.) , vol.200 , pp. 487-496
    • Egerton, A.1    Ahmad, R.2    Hirani, E.3    Grasby, P.M.4
  • 12
    • 70349330851 scopus 로고    scopus 로고
    • In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: Differential effects of inverse agonist versus antagonist
    • Leggio, G.M. et al. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J. Neurochem. 111, 614-623 (2009).
    • (2009) J. Neurochem. , vol.111 , pp. 614-623
    • Leggio, G.M.1
  • 13
    • 79961165805 scopus 로고    scopus 로고
    • Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
    • Spiros, A., Carr, R. & Geerts, H. Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse. Neuropsychiatr. Dis. Treat. 6, 589-603 (2010).
    • (2010) Neuropsychiatr. Dis. Treat. , vol.6 , pp. 589-603
    • Spiros, A.1    Carr, R.2    Geerts, H.3
  • 14
    • 0034213062 scopus 로고    scopus 로고
    • Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
    • Gobert, A. et al. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36, 205-221 (2000). (Pubitemid 30252995)
    • (2000) Synapse , vol.36 , Issue.3 , pp. 205-221
    • Gobert, A.1    Rivet, J.-M.2    Lejeune, F.3    Newman-Tancredi, A.4    Adhumeau-Auclair, A.5    Nicolas, J.-P.6    Cistarelli, L.7    Melon, C.8    Millan, M.J.9
  • 15
    • 77950195253 scopus 로고    scopus 로고
    • Safety, tolerability, and pharmacokinetics of multiple ascending oral doses of vabicaserin, a serotonin 2C agonist, in subjects with schizophrenia and schizoaffective discorder
    • Mako, B., Poola, N.R., Posener, J.A., & Paul, J. Safety, tolerability, and pharmacokinetics of multiple ascending oral doses of vabicaserin, a serotonin 2C agonist, in subjects with schizophrenia and schizoaffective discorder. Clin. Pharmacol. Ther. 83 (suppl. 1), S21 (2008).
    • (2008) Clin. Pharmacol. Ther. , vol.83 , Issue.SUPPL. 1
    • Mako, B.1    Poola, N.R.2    Posener, J.A.3    Paul, J.4
  • 16
    • 84863811015 scopus 로고    scopus 로고
    • A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia
    • Citrome, L. A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia. Expert Opin. Pharmacother. 13, 1545-1573 (2012).
    • (2012) Expert Opin. Pharmacother. , vol.13 , pp. 1545-1573
    • Citrome, L.1
  • 17
    • 0038653525 scopus 로고    scopus 로고
    • A meta-analysis of the efficacy of second-generation antipsychotics
    • Davis, J.M., Chen, N. & Glick, I.D. A meta-analysis of the efficacy of second-generation antipsychotics. Arch. Gen. Psychiatry 60, 553-564 (2003).
    • (2003) Arch. Gen. Psychiatry , vol.60 , pp. 553-564
    • Davis, J.M.1    Chen, N.2    Glick, I.D.3
  • 18
    • 84856513745 scopus 로고    scopus 로고
    • From the prodrome to chronic schizophrenia: The neurobiology underlying psychotic symptoms and cognitive impairments
    • Howes, O.D., Fusar-Poli, P., Bloomfield, M., Selvaraj, S. & McGuire, P. From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr. Pharm. Des. 18, 459-465 (2012).
    • (2012) Curr. Pharm. Des. , vol.18 , pp. 459-465
    • Howes, O.D.1    Fusar-Poli, P.2    Bloomfield, M.3    Selvaraj, S.4    McGuire, P.5
  • 19
    • 77950283731 scopus 로고    scopus 로고
    • SCA-136: A novel 5-HT2C receptor agonist possessing atypical antipsychotic-like effects in preclinical models
    • Washington, D.C., 14-18 October
    • Marquis, K.L., et al. SCA-136: a novel 5-HT2C receptor agonist possessing atypical antipsychotic-like effects in preclinical models. 36th Annual Meeting for the Society of Neuroscience, Washington, D.C., 14-18 October 2006.
    • (2006) 36th Annual Meeting for the Society of Neuroscience
    • Marquis, K.L.1
  • 20
    • 34250191571 scopus 로고    scopus 로고
    • Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: Implications for extrapyramidal side effects of serotonin reuptake inhibitors
    • DOI 10.1038/sj.npp.1301294, PII 1301294
    • Bonsi, P. et al. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32, 1840-1854 (2007). (Pubitemid 47076377)
    • (2007) Neuropsychopharmacology , vol.32 , Issue.8 , pp. 1840-1854
    • Bonsi, P.1    Cuomo, D.2    Ding, J.3    Sciamanna, G.4    Ulrich, S.5    Tscherter, A.6    Bernardi, G.7    Surmeier, D.J.8    Pisani, A.9
  • 21
    • 64849090472 scopus 로고    scopus 로고
    • Serotonin excites fast-spiking interneurons in the striatum
    • Blomeley, C.P. & Bracci, E. Serotonin excites fast-spiking interneurons in the striatum. Eur. J. Neurosci. 29, 1604-1614 (2009).
    • (2009) Eur. J. Neurosci. , vol.29 , pp. 1604-1614
    • Blomeley, C.P.1    Bracci, E.2
  • 22
    • 17644413790 scopus 로고    scopus 로고
    • Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: Role of CaV2.1 and CaV2.2 Ca2+ channels
    • Perez-Rosello, T. et al. Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels. J. Neurophysiol. 93, 2507-2519 (2005).
    • (2005) J. Neurophysiol. , vol.93 , pp. 2507-2519
    • Perez-Rosello, T.1
  • 23
    • 7444254932 scopus 로고    scopus 로고
    • Serotonin1B receptors: From protein to physiological function and behavior
    • DOI 10.1016/j.neubiorev.2004.08.008, PII S0149763404000880
    • Sari, Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 28, 565-582 (2004). (Pubitemid 39446482)
    • (2004) Neuroscience and Biobehavioral Reviews , vol.28 , Issue.6 , pp. 565-582
    • Sari, Y.1
  • 24
    • 2942735276 scopus 로고    scopus 로고
    • High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model
    • Rubin, J.E. & Terman, D. High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model. J. Comput. Neurosci. 16, 211-235 (2004).
    • (2004) J. Comput. Neurosci. , vol.16 , pp. 211-235
    • Rubin, J.E.1    Terman, D.2
  • 25
    • 79957615445 scopus 로고    scopus 로고
    • Multi-site stimulation of subthalamic nucleus diminishes thalamocortical relay errors in a biophysical network model
    • Guo, Y. & Rubin, J.E. Multi-site stimulation of subthalamic nucleus diminishes thalamocortical relay errors in a biophysical network model. Neural Netw. 24, 602-616 (2011).
    • (2011) Neural Netw. , vol.24 , pp. 602-616
    • Guo, Y.1    Rubin, J.E.2
  • 26
    • 0345167930 scopus 로고    scopus 로고
    • Delayed-Onset Hypothesis of Antipsychotic Action: A Hypothesis Tested and Rejected
    • DOI 10.1001/archpsyc.60.12.1228
    • Agid, O., Kapur, S., Arenovich, T. & Zipursky, R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 60, 1228-1235 (2003). (Pubitemid 37494076)
    • (2003) Archives of General Psychiatry , vol.60 , Issue.12 , pp. 1228-1235
    • Agid, O.1    Kapur, S.2    Arenovich, T.3    Zipursky, R.B.4
  • 28
    • 68149155596 scopus 로고    scopus 로고
    • Model based meta-analysis of positive and negative syndrome scale (PANSS) in schizphrenic patients
    • Ahadieh, S., Corrigan, B., Riley, S. & Lalonde, R. Model based meta-analysis of positive and negative syndrome scale (PANSS) in schizphrenic patients. Clin. Pharmacol. Ther. 85 (suppl. 1), S64 (2009).
    • (2009) Clin. Pharmacol. Ther. , vol.85 , Issue.SUPPL. 1
    • Ahadieh, S.1    Corrigan, B.2    Riley, S.3    Lalonde, R.4
  • 29
    • 84875951909 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: The use of PANSS total score and clinical utility
    • Pilla Reddy, V. et al. Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: the use of PANSS total score and clinical utility. Schizophr. Res. 146, 144-152 (2013).
    • (2013) Schizophr. Res. , vol.146 , pp. 144-152
    • Pilla Reddy, V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.